Paclitaxel: a new antineoplastic agent
Hitt, C.
Connecticut Medicine 58(3): 175-177
1994
ISSN/ISBN: 0010-6178 PMID: 7913673 Document Number: 438263
Document emailed within 1 workday
Related Documents
Socinski, M.A.; Langer, C.J. 1999: Single-agent paclitaxel and paclitaxel/non-platinum combination therapy in advanced non-small cell lung cancer Seminars in Oncology 26(5 Suppl 16: 51-61; Discussion: 71-72Royer, I.; Monsarrat, B.; Sonnier, M.; Wright, M.; Cresteil, T. 1996: Metabolism of docetaxel by human cytochromes P450: interactions with paclitaxel and other antineoplastic drugs Cancer Research 56(1): 58-65
Semonský, M.; Zikán, V.; Veselá, H. 1973: Cytembena Spofa--a new antineoplastic agent Ceskoslovenska Farmacie 22(7): 313-321
Inglot, A.D. 1980: Interferon as an antiviral, antineoplastic and immunomodulating agent Postepy Higieny i Medycyny Doswiadczalnej 34(2): 89-105
Gol'dberg, E.D.; Borovskaia, T.G.; Timina, E.A.; Fomina, T.I.; Gol'dberg, V.E. 1997: Spermatogenesis in rats after administration of the antineoplastic agent vepesid Biulleten' Eksperimental'noi Biologii i Meditsiny 124(12): 645-648
Pal, S.; Mukherjea, K.; Bhattacharya, R.; Maity, P. 1997: Pt-ATP as an antineoplastic agent in an experimental mice model system Journal of Experimental and Clinical Cancer Research: Cr 16(3): 255-260
Li, H.; Wu, K. 2004: Structural basis of alpha-tocopherol succinate as an antineoplastic agent Wei Sheng Yan Jiu 33(4): 512-514
Moriya, K.; Shimizu, H.; Handa, S.; Sasaki, T.; Sasaki, Y.; Takahashi, H.; Nakamura, S.; Yoshida, H.; Kato, Y. 2017: Incidence of Ophthalmic Disorders in Patients Treated with the Antineoplastic Agent S-1 Gan to Kagaku Ryoho. Cancer and ChemoTherapy 44(6): 501-506
Sampi, K.; Honda, T.; Hayashi, Y.; Hattori, M. 1983: Phase Ii study of a new anthraquinone antineoplastic agent, mitoxantrone, in hematological malignancies Gan to Kagaku Ryoho. Cancer and ChemoTherapy 10(6): 1538-1539
Beal, D.D.; Skibba, J.L.; Croft, W.A.; Cohen, S.M.; Bryan, G.T. 1975: Carcinogenicity of the antineoplastic agent, 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide, and its metabolites in rats Journal of the National Cancer Institute 54(4): 951-957
Dederer, L.I.; Lankin, V.Z.; Konovalova, A.L.; Gorbacheva, L.B. 1995: Biochemical mechanisms of resistance to a new antineoplastic agent amin(cyclopeptidylamin)-S-(-)-malatoplatinum (II) (cycloplatam) Biokhimiia 60(4): 602-609
Aneha, Y.; Kikuchi, K.; Kanno, H. 1974: Administration of antineoplastic agent of high molecular weight, neocarzinostatin, in cases of gastric cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 32(4): 870-874
Ho, Y.K. 1979: Studies on the mode of action of partially thiolated polycytidylic acid (MPC), a novel type of antineoplastic agent Research Communications in Chemical Pathology and Pharmacology 25(2): 293-306
Long, B.H.; Carboni, J.M.; Wasserman, A.J.; Cornell, L.A.; Casazza, A.M.; Jensen, P.R.; Lindel, T.; Fenical, W.; Fairchild, C.R. 1998: Eleutherobin, a novel cytotoxic agent that induces tubulin polymerization, is similar to paclitaxel (Taxol) Cancer Research 58(6): 1111-1115
Nishioka, B.; Ouchi, T.; Watanabe, S.; Umehara, M.; Yamane, E.; Yahata, K.; Muto, F.; Kojima, O.; Nomiyama, S.; Sakita, M.; Fujita, Y.; Majima, S. 1982: Follow-up study of preoperative oral administration of an antineoplastic agent as an adjuvant chemotherapy in stomach cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 9(8): 1427-1432
Furukawa, F.; Nagano, K.; Kokubo, T.; Kishimoto, Y.; Takahashi, M.; Hayashi, Y. 1983: Morphometric evaluation of nuclear size of transplantable gastric adenocarcinoma (SG2B) after antineoplastic agent administration Eisei Shikenjo Hokoku. Bulletin of National Institute of Hygienic Sciences 101: 66-70
Ota, T.; Takeshima, N.; Takizawa, K. 2011: Second-line chemotherapy for carboplatin/paclitaxel-refractory ovarian cancer: are multi-agent chemotherapies of little value truly? European Journal of Gynaecological Oncology 32(5): 471-475
Koga, S.; Shimizu, N.; Maeta, M.; Hamazoe, R.; Izumi, A. 1983: Application of heat combined with antineoplastic agent administration in the treatment of cancer (with special reference to malignancy of the digestive system) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 10(2 Pt 2): 358-365
Weng, W.L.; Lazo, J.S.; Gillis, C.N.; Pitt, B.R. 1990: Disposition of radioiodinated benzylguanidines in perfused rabbit lung: pharmacokinetics and effect of an organo-gold complexed antineoplastic agent Journal of Pharmacology and Experimental Therapeutics 255(1): 59-65
Olawaiye, A.B.; Godoy, H.E.; Shahzad, M.M.K.; Rauh-Hain, J.A.; Lele, S.B.; Odunsi, K. 2012: Comparison of outcomes in patients treated with multi-agent regiments of cisplatin, adriamycin, and VP-16 versus carboplatin and paclitaxel for advanced and recurrent endometrial cancer European Journal of Gynaecological Oncology 33(5): 477-479